Thiol-redox antioxidants protect against lung vascular endothelial cytoskeletal alterations caused by pulmonary fibrosis inducer, bleomycin: comparison between classical thiol-protectant, N-acetyl-l-cysteine, and novel thiol antioxidant, N,N′-bis-2-mercaptoethyl isophthalamide

References

• Antholine WE, Petering DH, Saryan LA, Brown CE. 1981. Interactions among iron(II) bleomycin, Lewis bases, and DNA. Proc Natl Acad Sci USA 78:7517–7520.
   PubMedGoogle Scholar
• Behr J, Ryu JH. 2008. Pulmonary hypertension in interstitial lung disease. Eur Respir J 31:1357–1367.
   PubMed Web of Science ®Google Scholar
• Bogatcheva NV, Verin AD. 2008. The role of cytoskeleton in the regulation of vascular endothelial barrier function. Microvasc Res 76:202–207.
   PubMedGoogle Scholar
• Burger RM, Peisach J, Blumberg WE, Horwitz SB. 1979. Iron-bleomycin interactions with oxygen and oxygen analogues. Effects on spectra and drug activity. J Biol Chem 254:10906–10912.
   PubMed Web of Science ®Google Scholar
• Calabrese F, Giacometti C, Rea F, Loy M, Valente M. 2005. Idiopathic interstitial pneumonias: Primum movens: epithelial, endothelial or whatever. Sarcoidosis Vasc Diffuse Lung Dis 22 Suppl 1:S15–S23.
   Google Scholar
• Chapman KE, Waters CM, Miller WM. 2002. Continuous exposure of airway epithelial cells to hydrogen peroxide: protection by KGF. J Cell Physiol 192:71–80.
   PubMed Web of Science ®Google Scholar
• Chiang ET, Camp SM, Dudek SM, Brown ME, Usatyuk PV, Zaborina O, Alverdy JC, Garcia JG. 2009. Protective effects of high-molecular weight polyethylene glycol (PEG) in human lung endothelial cell barrier regulation: role of actin cytoskeletal rearrangement. Microvasc Res 77:174–186.
   Google Scholar
• Cordier JF. 2008. [Pulmonary hypertension in chronic respiratory and cardiac diseases]. Rev Prat 58:2019–2023.
   Google Scholar
• Cortijo J, Cerdá-Nicolás M, Serrano A, Bioque G, Estrela JM, Santangelo F, Esteras A, Llombart-Bosch A, Morcillo EJ. 2001. Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats. Eur Respir J 17:1228–1235.
   PubMed Web of Science ®Google Scholar
• Crystal RG, Bitterman PB, Mossman B, Schwarz MI, Sheppard D, Almasy L, Chapman HA, Friedman SL, King TE Jr, Leinwand LA, Liotta L, Martin GR, Schwartz DA, Schultz GS, Wagner CR, Musson RA. 2002. Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med 166:236–246.
   PubMed Web of Science ®Google Scholar
• Dudek SM, Garcia JG. 2001. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 91:1487–1500.
   PubMed Web of Science ®Google Scholar
• Everett RS, Vanhook MK, Barozzi N, Toth I, Johnson LG. 2006. Specific modulation of airway epithelial tight junctions by apical application of an occludin peptide. Mol Pharmacol 69:492–500.
   Google Scholar
• Fang KC. 2000. Mesenchymal regulation of alveolar repair in pulmonary fibrosis. Am J Respir Cell Mol Biol 23:142–145.
   Google Scholar
• Fasano A. 2000. Regulation of intercellular tight junctions by zonula occludens toxin and its eukaryotic analogue zonulin. Ann N Y Acad Sci 915:214–222.
   PubMed Web of Science ®Google Scholar
• Ghio AJ. 2009. Disruption of iron homeostasis and lung disease. Biochim Biophys Acta 1790:731–739.
   PubMed Web of Science ®Google Scholar
• Gross TJ, Hunninghake GW. 2001. Idiopathic pulmonary fibrosis. N Engl J Med 345:517–525.
   PubMed Web of Science ®Google Scholar
• Hagele TJ, Mazerik JN, Gregory A, Kaufman B, Magalang U, Kuppusamy ML, Marsh CB, Kuppusamy P, Parinandi NL. 2007. Mercury activates vascular endothelial cell phospholipase D through thiols and oxidative stress. Int J Toxicol 26:57–69.
   Google Scholar
• Hagiwara SI, Ishii Y, Kitamura S. 2000. Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice. Am J Respir Crit Care Med 162:225–231.
   PubMed Web of Science ®Google Scholar
• Harhaj NS, Antonetti DA. 2004. Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol 36:1206–1237.
   PubMed Web of Science ®Google Scholar
• Huaux F, Liu T, McGarry B, Ullenbruch M, Xing Z, Phan SH. 2003. Eosinophils and T lymphocytes possess distinct roles in bleomycin-induced lung injury and fibrosis. J Immunol 171:5470–5481.
   Google Scholar
• Iyer SS, Ramirez AM, Ritzenthaler JD, Torres-Gonzalez E, Roser-Page S, Mora AL, Brigham KL, Jones DP, Roman J, Rojas M. 2009. Oxidation of extracellular cysteine/cystine redox state in bleomycin-induced lung fibrosis. Am J Physiol Lung Cell Mol Physiol 296:L37–L45.
   PubMed Web of Science ®Google Scholar
• Jackson RM. 1985. Pulmonary oxygen toxicity. Chest 88:900–905.
   PubMed Web of Science ®Google Scholar
• Kawkitinarong K, Linz-McGillem L, Birukov KG, Garcia JG. 2004. Differential regulation of human lung epithelial and endothelial barrier function by thrombin. Am J Respir Cell Mol Biol 31:517–527.
   PubMed Web of Science ®Google Scholar
• Kinnula VL, Myllärniemi M. 2008. Oxidant-antioxidant imbalance as a potential contributor to the progression of human pulmonary fibrosis. Antioxid Redox Signal 10:727–738.
   PubMed Web of Science ®Google Scholar
• Kinnula VL, Fattman CL, Tan RJ, Oury TD. 2005. Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy. Am J Respir Crit Care Med 172:417–422.
   PubMed Web of Science ®Google Scholar
• Li J, Poovey HG, Rodriguez JF, Brody A, Hoyle GW. 2004. Effect of platelet-derived growth factor on the development and persistence of asbestos-induced fibroproliferative lung disease. J Environ Pathol Toxicol Oncol 23:253–266.
   Google Scholar
• Magro CM, Allen J, Pope-Harman A, Waldman WJ, Moh P, Rothrauff S, Ross P Jr. 2003. The role of microvascular injury in the evolution of idiopathic pulmonary fibrosis. Am J Clin Pathol 119:556–567.
   PubMed Web of Science ®Google Scholar
• Matlock MM, Howerton BS, Atwood DA. 2001. Irreversibless precipitation of mercury and lead. J Hazard Mater 84:73–82.
   PubMed Web of Science ®Google Scholar
• Matlock MM, Howerton BS, Atwood DA (2003) Novel Multidentate Sulfur Containing Ligands. (University of Kentucky, Lexington, KY) U.S. Patent No. 6,586,600, July 1, 2003.
   Google Scholar
• Mazerik JN, Hagele T, Sherwani S, Ciapala V, Butler S, Kuppusamy ML, Hunter M, Kuppusamy P, Marsh CB, Parinandi NL. 2007. Phospholipase A2 activation regulates cytotoxicity of methylmercury in vascular endothelial cells. Int J Toxicol 26:553–569.
   Google Scholar
• Moore BB, Hogaboam CM. 2008. Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 294:L152–L160.
   PubMed Web of Science ®Google Scholar
• Oikonomou N, Harokopos V, Zalevsky J, Valavanis C, Kotanidou A, Szymkowski DE, Kollias G, Aidinis V. 2006. Soluble TNF mediates the transition from pulmonary inflammation to fibrosis. PLoS ONE 1:e108.
   PubMed Web of Science ®Google Scholar
• Parinandi NL, Scribner WM, Vepa S, Shi S, Natarajan V. 1999. Phospholipase D activation in endothelial cells is redox sensitive. Antioxid Redox Signal 1:193–210.
   PubMed Web of Science ®Google Scholar
• Parinandi NL, Roy S, Shi S, Cummings RJ, Morris AJ, Garcia JG, Natarajan V. 2001. Role of Src kinase in diperoxovanadate-mediated activation of phospholipase D in endothelial cells. Arch Biochem Biophys 396:231–243.
   PubMed Web of Science ®Google Scholar
• Patel RB, Kotha SR, Sherwani SI, Sliman SM, Gurney TO, Loar B, Butler SO, Morris AJ, Marsh CB, Parinandi NL. 2011. Pulmonary fibrosis inducer, bleomycin, causes redox-sensitive activation of phospholipase D and cytotoxicity through formation of bioactive lipid signal mediator, phosphatidic acid, in lung microvascular endothelial cells. Int J Toxicol 30:69–90.
   PubMedGoogle Scholar
• Petri B, Bixel MG. 2006. Molecular events during leukocyte diapedesis. FEBS J 273:4399–4407.
   PubMed Web of Science ®Google Scholar
• Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J, Brigham KL. 2005. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 33:145–152.
   PubMed Web of Science ®Google Scholar
• Ryu JH, Krowka MJ, Pellikka PA, Swanson KL, McGoon MD. 2007. Pulmonary hypertension in patients with interstitial lung diseases. Mayo Clin Proc 82:342–350.
   PubMed Web of Science ®Google Scholar
• Serrano-Mollar A, Closa D, Prats N, Blesa S, Martinez-Losa M, Cortijo J, Estrela JM, Morcillo EJ, Bulbena O. 2003. In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats. Br J Pharmacol 138:1037–1048.
   PubMed Web of Science ®Google Scholar
• Sliman SM, Eubank TD, Kotha SR, Kuppusamy ML, Sherwani SI, Butler ES, Kuppusamy P, Roy S, Marsh CB, Stern DM, Parinandi NL. 2010. Hyperglycemic oxoaldehyde, glyoxal, causes barrier dysfunction, cytoskeletal alterations, and inhibition of angiogenesis in vascular endothelial cells: aminoguanidine protection. Mol Cell Biochem 333:9–26.
   Google Scholar
• Steinhour E, Sherwani SI, Mazerik JN, Ciapala V, O’Connor Butler E, Cruff JP, Magalang U, Parthasarathy S, Sen CK, Marsh CB, Kuppusamy P, Parinandi NL. 2008. Redox-active antioxidant modulation of lipid signaling in vascular endothelial cells: vitamin C induces activation of phospholipase D through phospholipase A2, lipoxygenase, and cyclooxygenase. Mol Cell Biochem 315:97–112.
   Google Scholar
• Tao F, Gonzalez-Flecha B, Kobzik L. 2003. Reactive oxygen species in pulmonary inflammation by ambient particulates. Free Radic Biol Med 35:327–340.
   PubMed Web of Science ®Google Scholar
• Tashiro M, Izumikawa K, Yoshioka D, Nakamura S, Kurihara S, Sakamoto N, Seki M, Kakeya H, Yamamoto Y, Yanagihara K, Mukae H, Hayashi T, Fukushima K, Tashiro T, Kohno S. 2008. Lung fibrosis 10 years after cessation of bleomycin therapy. Tohoku J Exp Med 216:77–80.
   PubMed Web of Science ®Google Scholar
• Taskar V, Coultas D. 2008. Exposures and idiopathic lung disease. Semin Respir Crit Care Med 29:670–679.
   Google Scholar
• Uchida K. 2003. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res 42:318–343.
   PubMed Web of Science ®Google Scholar
• Usatyuk PV, Parinandi NL, Natarajan V. 2006. Redox regulation of 4-hydroxy-2-nonenal-mediated endothelial barrier dysfunction by focal adhesion, adherens, and tight junction proteins. J Biol Chem 281:35554–35566.
   PubMed Web of Science ®Google Scholar
• Usatyuk PV, Vepa S, Watkins T, He D, Parinandi NL, Natarajan V. 2003. Redox regulation of reactive oxygen species-induced p38 MAP kinase activation and barrier dysfunction in lung microvascular endothelial cells. Antioxid Redox Signal 5:723–730.
   PubMed Web of Science ®Google Scholar
• Utech M, Brüwer M, Nusrat A. 2006. Tight junctions and cell-cell interactions. Methods Mol Biol 341:185–195.
   PubMedGoogle Scholar
• Vaillant P, Menard O, Vignaud JM, Martinet N, Martinet Y. 1996. The role of cytokines in human lung fibrosis. Monaldi Arch Chest Dis 51:145–152.
   PubMedGoogle Scholar
• Van Itallie CM, Anderson JM. 2006. Claudins and epithelial paracellular transport. Annu Rev Physiol 68:403–429.
   PubMed Web of Science ®Google Scholar
• Vandenbroucke E, Mehta D, Minshall R, Malik AB. 2008. Regulation of endothelial junctional permeability. Ann N Y Acad Sci 1123:134–145.
   PubMed Web of Science ®Google Scholar
• Varadharaj S, Steinhour E, Hunter MG, Watkins T, Baran CP, Magalang U, Kuppusamy P, Zweier JL, Marsh CB, Natarajan V, Parinandi NL. 2006. Vitamin C-induced activation of phospholipase D in lung microvascular endothelial cells: regulation by MAP kinases. Cell Signal 18:1396–1407.
   PubMed Web of Science ®Google Scholar
• Warshamana GS, Pociask DA, Fisher KJ, Liu JY, Sime PJ, Brody AR. 2002. Titration of non-replicating adenovirus as a vector for transducing active TGF-beta1 gene expression causing inflammation and fibrogenesis in the lungs of C57BL/6 mice. Int J Exp Pathol 83:183–201.
   PubMed Web of Science ®Google Scholar
• Wilson MS, Wynn TA. 2009. Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol 2:103–121.
   PubMed Web of Science ®Google Scholar
• Xu Y, Gong B, Yang Y, Awasthi YC, Woods M, Boor PJ. 2007. Glutathione-S-transferase protects against oxidative injury of endothelial cell tight junctions. Endothelium 14:333–343.
   PubMed Web of Science ®Google Scholar
• Yin Q, Nan H, Yan L, Huang X, Wang W, Cui G, Wei J. 2012. Alteration of tight junctions in pulmonary microvascular endothelial cells in bleomycin-treated rats. Exp Toxicol Pathol 64:81–91.
   Google Scholar
• Zaman KM, Blue LY, Huggins FE, Atwood DA. 2007. Cd, Hg, and Pb Compounds of Benzene-1,3-diamidoethanethiol (BDETH(2)). Inorg Chem 46:1975–1980.
   PubMed Web of Science ®Google Scholar
• Zisman DA, Keane MP, Belperio JA, Strieter RM, Lynch JP 3rd. 2005. Pulmonary fibrosis. Methods Mol Med 117:3–44.
   PubMedGoogle Scholar